Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS). (2018)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2017.08.018
PubMed Identifier: 28935163
Publication URI: http://europepmc.org/abstract/MED/28935163
Type: Journal Article/Review
Volume: 73
Parent Publication: European urology
Issue: 1
ISSN: 0302-2838